BioTechX Europe 2026 has ended. This guide stays up as the record of who was there. Next: BioTechX Europe 2027, Oct 11–13, 2027 in Basel

JJ

Johnson & Johnson Innovative Medicine at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

Johnson & Johnson Innovative Medicine takes part in 2 sessions at BioTechX Europe 2026 in Basel. Its sessions centre on AI in clinical trials. Topics include predicting which patients are likely to drop out of a trial so teams can keep them enrolled, and, with SAS, turning long-standing clinical know-how into AI agents that coordinate R&D work.

OrganizationBioTechX Europe 2026 Attendance
JJ
Johnson & Johnson Innovative Medicine
Large pharma
Pharmaceutical business of Johnson & Johnson, formerly Janssen.
Talk
Wed Oct 7
12:05
Orchestrating the Future of Clinical R&D: From Long-established Expertise to AI‑Driven Expert Agents
How specialist AI assistants for data handling, statistics and reporting could reshape clinical research work, with human experts directing them.
with SAS
Talk
Thu Oct 8
11:50
Improving Clinical Trial Retention with AI-Powered Dropout Risk Prediction
Data Integration + FAIR

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson Innovative Medicine

Tell us what you sell and we’ll find the people at Johnson & Johnson Innovative Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BioTechX or its organizers. Submit a correction